Value of Human Immunodeficiency Virus (HIV) Diagnostics

Despite advances in treatment, the HIV/Acquired Immunodeficiency Syndrome (AIDS) pandemic remains one of the biggest challenges for global public health care.  Because there is currently no cure for HIV infection, early detection is critical to control the continued spread of HIV infection.

Improved HIV-1 Screening Tests

Avioq is a medical device company dedicated to developing advanced immunodiagnostic products.  Avioq’s first product, the Avioq HIV-1 Microelisa System, recently received FDA’s approval for use as an aid in diagnosis of infection with HIV-1.  The Avioq HIV-1 Microelisa System is currently the only assay FDA approved for use with Oral Fluid specimens.

• The same product is utilized for testing four different specimen types: serum, plasma, dried blood spots, and oral fluid
• Product enhancements provide increased adaptability to automated instrumentation

Applications

Antibody testing with Serum, Plasma, Oral Fluid, and Dried Blood Spots at Reference Laboratories, Departments of Health, Hospitals, Insurance Laboratories, and other Laboratories performing HIV-1 diagnostic testing.

Quality Products and Service

At Avioq, we are committed to developing advanced immunodiagnostic products and to providing the highest quality service to our worldwide customers.